Opus subsidiary remains king of public procurements
Due to escalating conflict
Key dates published
1,190 new cases, 71 fatalities on Thursday
In a multi-step deal
Price reported to be EUR 1 bn
Q1 operating profit 22% above expected
For shareholder remuneration
Shares good news about dividend
Impact of pandemic petering out
No new record in sales this quarter
It's been a great tool, though
Not that there was any doubt it would deliver
Oil prices rise, outlook improves
Aims for number one position
Developed by Sinovac
Believes litigation is without merit
Interview with Gábor Győrfi